{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:23:34Z","timestamp":1793863414284,"version":"4.6.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.05.073","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T08:43:59Z","timestamp":1213778639000},"page":"4434-4445","source":"Crossref","is-referenced-by-count":130,"title":["Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae"],"prefix":"10.1016","volume":"26","author":[{"given":"Caroline L.","family":"Trotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"McVernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia G.","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Hombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.vaccine.2008.05.073_bib1","first-page":"445","article-title":"WHO position paper on Haemophilus influenzae type b conjugate vaccines (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record)","volume":"81","author":"Anon","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0022172400028783","article-title":"Observations on the nasopharyngeal carriage of Haemophilus influenzae type b in children in Kampala, Uganda","volume":"68","author":"Mpairwe","year":"1970","journal-title":"J Hyg (Lond)"},{"issue":"9 Suppl.","key":"10.1016\/j.vaccine.2008.05.073_bib3","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/00006454-199809001-00018","article-title":"A population-based survey of Haemophilus influenzae type b nasopharyngeal carriage prevalence in Lombok Island, Indonesia","volume":"17","author":"Gessner","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/315018","volume":"180","author":"Forleo-Neto","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0035-9203(89)90345-3","article-title":"Carriage of Haemophilus influenzae in healthy Gambian children","volume":"83","author":"Bijlmer","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1086\/517440","article-title":"Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children","volume":"177","author":"Adegbola","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S0950268898008784","article-title":"Mathematical models of Haemophilus influenzae type b","volume":"120","author":"Coen","year":"1998","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4161\/hv.2.1.2445","article-title":"Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults","volume":"2","author":"Dentinger","year":"2006","journal-title":"Hum Vaccin"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.05.073_bib9","first-page":"3","article-title":"La meningite cerebrospinale en Afrique","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"96","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.05.073_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"22","key":"10.1016\/j.vaccine.2008.05.073_bib12","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.073_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1017\/S0950268807008825","article-title":"The changing face of meningococcal disease in West Africa","volume":"135","author":"Greenwood","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.05.073_bib14","unstructured":"EU-IBIS Network. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London; 2007 Sep."},{"issue":"9580","key":"10.1016\/j.vaccine.2008.05.073_bib15","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.073_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268800066449","article-title":"The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica","volume":"99","author":"Cartwright","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.05.073_bib17","series-title":"Meningococcal disease","first-page":"115","article-title":"Meningococcal carriage and disease","author":"Cartwright","year":"1995"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2008.05.073_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/jmm.0.45529-0","article-title":"Neisseria meningitidis: an overview of the carriage state","volume":"53","author":"Yazdankhah","year":"2004","journal-title":"J Med Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.073_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt: a review","volume":"7","author":"Trotter","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.073_bib20","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization \u2013 WHO position paper","volume":"82","author":"Anon.","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"36","key":"10.1016\/j.vaccine.2008.05.073_bib22","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1016\/j.vaccine.2007.06.044","article-title":"WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26\u201327 October 2006, Geneva","volume":"25","author":"Cherian","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.073_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(05)70189-4","article-title":"Antimicrobial resistance in developing countries. Part I: recent trends and current status","volume":"5","author":"Okeke","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.05.073_bib25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O\u2019Brien","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-3156.2006.01565.x","article-title":"Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique","volume":"11","author":"Valles","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00006454-199310000-00006","article-title":"Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance","volume":"12","author":"Mastro","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/tropej\/34.3.114","article-title":"Throat carriage of Streptococcus pneumoniae and Streptococcus pyogenes among infants and children in Zambia","volume":"34","author":"Frederiksen","year":"1988","journal-title":"J Trop Pediatr"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.073_bib30","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/JCM.32.12.2948-2952.1994","article-title":"Pneumococci in nasopharyngeal samples from Filipino children with acute respiratory infections","volume":"32","author":"Lankinen","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000242576","article-title":"Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers","volume":"50","author":"Gratten","year":"1986","journal-title":"Biol Neonate"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.inf.0000257425.24492.11","article-title":"Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh","volume":"26","author":"Granat","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/14740338.5.3.351","article-title":"Combination conjugate vaccines","volume":"5","author":"Bar-Zeev","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"9 Suppl.","key":"10.1016\/j.vaccine.2008.05.073_bib35","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00006454-199809001-00004","article-title":"Haemophilus influenzae type b vaccines: history, choice and comparisons","volume":"17","author":"Decker","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.073_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"31","key":"10.1016\/j.vaccine.2008.05.073_bib37","first-page":"794","article-title":"Revised recommendations of the advisory committee on immunization practices to vaccinate all persons aged 11\u201318 years with meningococcal conjugate vaccine","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2008.05.073_bib38","unstructured":"Chief Medical Officer, Chief nursing officer, Chief pharmacist. Planned changes to the routine childhood immunisation programme; 2006. Available from (accessed 7th May 2008) http:\/\/www.dh.gov.uk\/assetRoot\/04\/12\/81\/21\/04128121.pdf."},{"issue":"S","key":"10.1016\/j.vaccine.2008.05.073_bib39","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The Meningitis Vaccine Project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00006454-200010000-00001","article-title":"A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine","volume":"19","author":"Robbins","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.073_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM198709173171201","article-title":"Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy","volume":"317","author":"Eskola","year":"1987","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.vaccine.2008.05.073_bib42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1542\/peds.92.2.272","article-title":"Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group","volume":"92","author":"Vadheim","year":"1993","journal-title":"Pediatrics"},{"issue":"8919","key":"10.1016\/j.vaccine.2008.05.073_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(94)91400-1","article-title":"Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T","volume":"344","author":"Booy","year":"1994","journal-title":"Lancet"},{"issue":"9 Suppl.","key":"10.1016\/j.vaccine.2008.05.073_bib46","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00006454-199809001-00005","article-title":"Haemophilus influenzae type b conjugate vaccines: a review of efficacy data","volume":"17","author":"Heath","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"25","key":"10.1016\/j.vaccine.2008.05.073_bib47","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","article-title":"The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex","volume":"324","author":"Santosham","year":"1991","journal-title":"N Engl J Med"},{"issue":"9060","key":"10.1016\/j.vaccine.2008.05.073_bib48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.073_bib49","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib50","first-page":"275","article-title":"Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project","volume":"22","author":"Soriano-Gabarro","year":"2004","journal-title":"J Health Popul Nutr"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.073_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"9381","key":"10.1016\/j.vaccine.2008.05.073_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib54","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.073_bib56","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"9465","key":"10.1016\/j.vaccine.2008.05.073_bib57","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib58","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1371\/journal.pmed.0050087","article-title":"Progress in vaccination against Haemophilus influenzae type b in the Americas","volume":"5","author":"Danovaro-Holliday","year":"2008","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.073_bib59","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-199511000-00011","article-title":"Post-licensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up","volume":"14","author":"Shinefield","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3201\/eid0402.980210","article-title":"Haemophilus influenzae invasive disease in the United States, 1994\u20131995: near disappearance of a vaccine-preventable childhood disease","volume":"4","author":"Bisgard","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.073_bib61","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/00006454-199809001-00008","article-title":"Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada","volume":"17","author":"Wenger","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"S9","key":"10.1016\/j.vaccine.2008.05.073_bib62","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1097\/00006454-199809001-00026","article-title":"Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines","volume":"17","author":"Slack","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib63","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-3476(97)70035-0","article-title":"Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity","volume":"131","author":"van","year":"1997","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0264-410X(98)00165-0","article-title":"Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"},{"issue":"8813","key":"10.1016\/j.vaccine.2008.05.073_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0140-6736(92)90529-C","article-title":"Immunisation of infants in Iceland against Haemophilus influenzae type b","volume":"340","author":"Jonsdottir","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/314535","article-title":"Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia","volume":"179","author":"Peltola","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/080352500750028212","article-title":"Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children","volume":"89","author":"Garpenholt","year":"2000","journal-title":"Acta Paediatr"},{"issue":"7481","key":"10.1016\/j.vaccine.2008.05.073_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.38301.657014.79","article-title":"Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data","volume":"330","author":"Peltola","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib69","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302-317.2000","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1067\/mpd.2000.107843","article-title":"Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage","volume":"137","author":"Singleton","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib71","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-3476(94)70009-5","article-title":"Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children","volume":"125","author":"Harrison","year":"1994","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0950268801005155","article-title":"The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data","volume":"126","author":"Markey","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"9480","key":"10.1016\/j.vaccine.2008.05.073_bib73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(05)66788-8","article-title":"Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study","volume":"366","author":"Adegbola","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.073_bib74","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.inf.0000137575.82874.0c","article-title":"Impact of Haemophilus influenzae type b conjugate vaccine in South Africa and Argentina","volume":"23","author":"Martin","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib75","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2471\/BLT.06.030361","article-title":"Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa","volume":"84","author":"von Gottberg","year":"2006","journal-title":"Bull World Health Organ"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2008.05.073_bib76","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2006.05.076","article-title":"The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence","volume":"24","author":"Daza","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.296.6.671","article-title":"Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya","volume":"296","author":"Cowgill","year":"2006","journal-title":"JAMA"},{"issue":"9 Suppl.","key":"10.1016\/j.vaccine.2008.05.073_bib78","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/00006454-199809001-00010","article-title":"The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries","volume":"17","author":"Lagos","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ije\/dyh025","article-title":"Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil","volume":"33","author":"de Andrade","year":"2004","journal-title":"Int J Epidemiol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.05.073_bib80","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0264-410X(99)00269-8","article-title":"Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four \u2018newly adopting\u2019 countries","volume":"18","author":"Wenger","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib81","first-page":"61","article-title":"The challenge of ongoing Haemophilus influenzae type B carriage and transmission in Alaska","volume":"41","author":"Lucher","year":"1999","journal-title":"Alaska Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib82","first-page":"55","article-title":"Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign","volume":"6","author":"Trotter","year":"2003","journal-title":"Commun Dis Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.073_bib83","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ije\/22.4.742","article-title":"Estimation of vaccine effectiveness using the screening method","volume":"22","author":"Farrington","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.05.073_bib84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"issue":"9368","key":"10.1016\/j.vaccine.2008.05.073_bib85","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(03)13172-8","article-title":"Antibody to Haemophilus influenzae type b after routine and catch-up vaccination","volume":"361","author":"Trotter","year":"2003","journal-title":"Lancet"},{"issue":"7467","key":"10.1016\/j.vaccine.2008.05.073_bib86","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.329.7467.655","article-title":"Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study","volume":"329","author":"McVernon","year":"2004","journal-title":"BMJ"},{"issue":"9368","key":"10.1016\/j.vaccine.2008.05.073_bib87","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.073_bib88","first-page":"E050929","article-title":"Vaccination catch-up campaign in response to recent increase in Hib infection in Ireland","volume":"10","author":"Fitzgerald","year":"2005","journal-title":"Euro Surveill"},{"issue":"9368","key":"10.1016\/j.vaccine.2008.05.073_bib89","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0140-6736(03)13201-1","article-title":"Return of Haemophilus influenzae type b infections","volume":"361","author":"Rijkers","year":"2003","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.vaccine.2008.05.073_bib90","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2007.06.023","article-title":"Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine","volume":"25","author":"Howie","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.073_bib91","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.073_bib92","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Effectiveness of meningococcal C conjugate vaccine in teenagers in England","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"issue":"9431","key":"10.1016\/j.vaccine.2008.05.073_bib93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.vaccine.2008.05.073_bib94","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2008.05.073_bib95","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine","volume":"292","author":"De","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.05.073_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6976.2006.00060.x","article-title":"A surveillance network for meningococcal disease in Europe","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"18","key":"10.1016\/j.vaccine.2008.05.073_bib98","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.vaccine.2008.05.073_bib99","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease \u2013 United States, 1998\u20132003","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3 Pt 1","key":"10.1016\/j.vaccine.2008.05.073_bib100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib101","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1503\/cmaj.051150","article-title":"Progress in the prevention of pneumococcal infection","volume":"173","author":"Kellner","year":"2005","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib102","first-page":"18","article-title":"Invasive pneumococcal disease in Australia, 2006","volume":"32","author":"Roche","year":"2008","journal-title":"Commun Dis Intell"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.073_bib103","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.vaccine.2005.12.025","article-title":"Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens","volume":"24","author":"Mahon","year":"2006","journal-title":"Vaccine"},{"issue":"9546","key":"10.1016\/j.vaccine.2008.05.073_bib104","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib106","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.2006-0492","article-title":"National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States","volume":"118","author":"Grijalva","year":"2006","journal-title":"Pediatrics"},{"issue":"9568","key":"10.1016\/j.vaccine.2008.05.073_bib107","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.073_bib108","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with a Hib conjugate vaccine","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.073_bib109","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006454-199307000-00009","article-title":"Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines","volume":"12","author":"Mohle-Boetani","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-3476(99)70438-5","article-title":"Infant Hib vaccination and herd immunity","volume":"134","author":"Rushdy","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.05.073_bib111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/171.1.93","article-title":"The impact of conjugate vaccine on carriage of Haemophilus influenzae type b","volume":"171","author":"Barbour","year":"1995","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib112","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3476(05)83529-2","article-title":"Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine","volume":"122","author":"Murphy","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.05.073_bib113","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci one year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"7385","key":"10.1016\/j.vaccine.2008.05.073_bib114","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"Trotter","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib116","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.073_bib117","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.073_bib118","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.073_bib119","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children ina community-randomized trial","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.073_bib120","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/423379","article-title":"Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life","volume":"39","author":"Ghaffar","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.073_bib121","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.inf.0000143645.58215.f0","article-title":"Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates","volume":"23","author":"Pelton","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.073_bib122","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.inf.0000187030.83080.8a","article-title":"Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae with prolonged vaccine dosing intervals","volume":"24","author":"Jones","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib123","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.073_bib124","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2008.05.073_bib125","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","article-title":"Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska natives: progress towards elimination of a health disparity","volume":"23","author":"Hennessy","year":"2005","journal-title":"Vaccine"},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2008.05.073_bib126","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1016\/j.vaccine.2005.05.043","article-title":"Declining invasive pneumococcal disease in the U.S. elderly","volume":"23","author":"McBean","year":"2005","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.073_bib127","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"issue":"9583","key":"10.1016\/j.vaccine.2008.05.073_bib128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)61119-2","article-title":"Herd immunity after pneumococcal conjugate vaccination","volume":"370","author":"Albrich","year":"2007","journal-title":"Lancet"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.05.073_bib129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0264-410X(01)00449-2","article-title":"Impact of a regional Hib vaccination programme in Italy","volume":"20","author":"Gallo","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/aje\/kwi160","article-title":"Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination","volume":"162","author":"Trotter","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.05.073_bib131","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and imunogenicity in UK infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.073_bib132","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib133","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib134","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2005.07.060","article-title":"Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP\/Hib vaccine","volume":"24","author":"Southern","year":"2006","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.05.073_bib135","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2004.02.028","article-title":"Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A\/C-diphtheria toxoid conjugate vaccine in infants in Niger","volume":"22","author":"Chippaux","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib136","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1465-9921-8-12","article-title":"Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age","volume":"8","author":"Esposito","year":"2007","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.073_bib137","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib138","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/CVI.00191-07","volume":"14","author":"Southern","year":"2007","journal-title":"Clin Vac Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.073_bib139","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.vaccine.2004.09.029","article-title":"Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants","volume":"23","author":"Esposito","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.073_bib140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"Kayhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib141","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/504802","article-title":"Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population","volume":"43","author":"Millar","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.073_bib143","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3201\/eid0503.990304","article-title":"Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae","volume":"5","author":"Lipsitch","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.073_bib144","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2008.05.073_bib146","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.vaccine.2008.05.073_bib147","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine","volume":"25","author":"Madhi","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.073_bib148","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00006454-200210000-00011","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine","volume":"21","author":"Obaro","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2008.05.073_bib149","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.073_bib150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/518438","article-title":"Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.073_bib151","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination","volume":"5","author":"Kayhty","year":"2006","journal-title":"Expert Rev Vac"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.073_bib152","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.vaccine.2005.08.092","article-title":"Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination","volume":"24","author":"Barzilay","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.073_bib153","first-page":"399","article-title":"Equity and child-survival strategies","volume":"86","author":"Mulholland","year":"2008","journal-title":"Bull WHO"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:56:24Z","timestamp":1684443384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08006841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":153,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0264410X08006841"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}